187 related articles for article (PubMed ID: 27129239)
1. RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells.
Wynn ML; Yates JA; Evans CR; Van Wassenhove LD; Wu ZF; Bridges S; Bao L; Fournier C; Ashrafzadeh S; Merrins MJ; Satin LS; Schnell S; Burant CF; Merajver SD
J Biol Chem; 2016 Jun; 291(26):13715-29. PubMed ID: 27129239
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.
Joglekar M; Elbezanti WO; Weitzman MD; Lehman HL; van Golen KL
J Cell Biochem; 2015 Jun; 116(6):923-33. PubMed ID: 25559359
[TBL] [Abstract][Full Text] [Related]
3. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.
Kleer CG; Zhang Y; Pan Q; Gallagher G; Wu M; Wu ZF; Merajver SD
Breast Cancer Res; 2004; 6(1):R110-5. PubMed ID: 14696649
[TBL] [Abstract][Full Text] [Related]
4. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.
van Golen KL; Wu ZF; Qiao XT; Bao L; Merajver SD
Neoplasia; 2000; 2(5):418-25. PubMed ID: 11191108
[TBL] [Abstract][Full Text] [Related]
5. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.
Allen SG; Chen YC; Madden JM; Fournier CL; Altemus MA; Hiziroglu AB; Cheng YH; Wu ZF; Bao L; Yates JA; Yoon E; Merajver SD
Sci Rep; 2016 Dec; 6():39190. PubMed ID: 27991524
[TBL] [Abstract][Full Text] [Related]
6. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase.
Lehman HL; Van Laere SJ; van Golen CM; Vermeulen PB; Dirix LY; van Golen KL
Mol Cancer Res; 2012 Oct; 10(10):1306-18. PubMed ID: 22896661
[TBL] [Abstract][Full Text] [Related]
7. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
[TBL] [Abstract][Full Text] [Related]
8. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.
van Golen KL; Bao L; DiVito MM; Wu Z; Prendergast GC; Merajver SD
Mol Cancer Ther; 2002 Jun; 1(8):575-83. PubMed ID: 12479217
[TBL] [Abstract][Full Text] [Related]
9. Modeling and characterization of inflammatory breast cancer emboli grown in vitro.
Lehman HL; Dashner EJ; Lucey M; Vermeulen P; Dirix L; Van Laere S; van Golen KL
Int J Cancer; 2013 May; 132(10):2283-94. PubMed ID: 23129218
[TBL] [Abstract][Full Text] [Related]
10. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.
van Golen KL; Bao LW; Pan Q; Miller FR; Wu ZF; Merajver SD
Clin Exp Metastasis; 2002; 19(4):301-11. PubMed ID: 12090470
[TBL] [Abstract][Full Text] [Related]
11. RhoC impacts the metastatic potential and abundance of breast cancer stem cells.
Rosenthal DT; Zhang J; Bao L; Zhu L; Wu Z; Toy K; Kleer CG; Merajver SD
PLoS One; 2012; 7(7):e40979. PubMed ID: 22911725
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
13. Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype.
Chatterjee M; van Golen KL
Int J Cancer; 2011 Jul; 129(1):61-9. PubMed ID: 20824700
[TBL] [Abstract][Full Text] [Related]
14. Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients.
Lo AC; Georgopoulos A; Kleer CG; Banerjee M; Omar S; Khaled H; Eissa S; Hablas A; Omar HG; Douglas JA; Merajver SD; Soliman AS
Breast; 2009 Feb; 18(1):55-9. PubMed ID: 19157876
[TBL] [Abstract][Full Text] [Related]
15. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
16. Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients.
Marrakchi R; Khadimallah I; Ouerhani S; Gamoudi A; Khomsi F; Bouzaine H; Benamor M; Bougatef K; Mnif S; Zitoun R; Benna F; Boussen H; Rahal K; Elgaaied AB
Cancer Invest; 2010 May; 28(4):399-407. PubMed ID: 20014943
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco.
Soliman AS; Kleer CG; Mrad K; Karkouri M; Omar S; Khaled HM; Benider AL; Ayed FB; Eissa SS; Eissa MS; McSpadden EJ; Lo AC; Toy K; Kantor ED; Xiao Q; Hampton C; Merajver SD
Breast Dis; 2011-2012; 33(4):159-69. PubMed ID: 23001584
[TBL] [Abstract][Full Text] [Related]
18. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.
van Golen KL; Davies S; Wu ZF; Wang Y; Bucana CD; Root H; Chandrasekharappa S; Strawderman M; Ethier SP; Merajver SD
Clin Cancer Res; 1999 Sep; 5(9):2511-9. PubMed ID: 10499627
[TBL] [Abstract][Full Text] [Related]
19. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
20. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
